Dishman Carbogen Amcis Ltd
Premium PartnerChina
Drug Product
Advanced Modalities
Analytical & Bioanalytical Services
Company Overview
About
Dishman Carbogen Amcis Ltd is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:China
Founded:2015
Employees:2,099
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Technology Platforms
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
North America
Europe
Manufacturing Facilities
6 sites worldwide
Dishman Carbogen Amcis Ltd - China Facility
China
Site Capabilities
Gene Therapy
Cell Therapy
mRNA
Dishman Carbogen Amcis Ltd - France Facility
France
Site Capabilities
Gene Therapy
Cell Therapy
mRNA
Dishman Carbogen Amcis Ltd - India Facility
India
Site Capabilities
Gene Therapy
Cell Therapy
mRNA
Dishman Carbogen Amcis Ltd - Netherlands Facility
Netherlands
Site Capabilities
Gene Therapy
Cell Therapy
mRNA
Dishman Carbogen Amcis Ltd - Switzerland Facility
Switzerland
Site Capabilities
Gene Therapy
Cell Therapy
mRNA
Dishman Carbogen Amcis Ltd - United Kingdom Facility
United Kingdom
Site Capabilities
Gene Therapy
Cell Therapy
mRNA
Regulatory Approvals
Drug Approval X0RLQ2
Health Canada · #APR-0SXZQCV4 · 2020-09-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Customer Reviews
No reviews available yet.
Company Documents
No documents available.
Loading CDMO intelligence...